Physician profile
Mark Langsfeld
NPI 1528074176
$1,042.23
in general payments reported to CMS, 2019-2025
13 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $235 · 2022: $27.55 · 2024: $78.01 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $474.71 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Tactile Systems Technology INC | $218.39 | 2019-2025 | Nimbl, Flexitouch Plus |
| Lemaitre Vascular, INC. | $78.01 | 2024 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft |
| Artivion, INC. | $39.07 | 2019 | |
| Biocompatibles, INC. | $35.16 | 2019 | |
| Medtronic Vascular, INC. | $34.87 | 2019 | |
| Penumbra, INC. | $33.36 | 2025 | Ruby Coil |
| Cook Medical LLC | $29.76 | 2019 | |
| Bard Peripheral Vascular, INC. | $27.55 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.07 | 2019 | |
| Getinge USA Sales, LLC | $18.52 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.09 | 2019 | |
| Amgen INC. | $15.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Langsfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.